Research and specialist diagnostic molecular services
We are a biomedical company with extensive experience in the molecular diagnostic field that allows us to improve the patient’s life quality by putting genetics at their service.
Research and specialist diagnostic molecular services
We are a biomedical company with extensive experience in the molecular diagnostic field that allows us to improve the patient’s life quality by putting genetics at their service.
“In situ” hybridization (FISH)
Highly sensitive technique that allows us to detect chromosomal alterations (number of copies of a gene or a chromosomal rearrangements) in different neoplasms for diagnosis and/or targeted treatment, using probes labeled with a fluorochrome.
Molecular Biology
Molecular biology tools allow us to specifically detect and quantify the genetic material in a biological sample, having a great impact on both the diagnosis of cancer and hereditary and infectious diseases. The appearance of new faster and more precise techniques (arrays or NGS), allow us to perform global genomic analyzes in a short period of time.
News
NOVARTIS PIQRAY® RECEIVES POSITIVE CHMP OPINION TO TREAT
Novartis announced the Committee for Medicinal Products for Human Use (CHMP) of the European
FDA APPROVES FIRST THERAPY FOR PATIENTS WITH LUNG
The U.S. Food and Drug Administration (FDA), approved Retevmo (selpercatinib) capsules to treat three
KRAS GENE AMPLIFICATION IN COLORECTAL CANCER AND IMPACT
KRAS mutations are the most common oncogenic event in colorectal cancer (CRC) progression and
FDA APPROVES FIRST NEW DRUG UNDER INTERNATIONAL COLLABORATION,
As part of Project Orbis, the U.S. Food and Drug Administration approved Tukysa (tucatinib) in
VALIDATION AND REFINEMENT OF THE REVISED 2017 EUROPEAN
The revised 2017 European LeukemiaNet (ELN) recommendations for genetic risk stratification of acute myeloid
